Debate: Value to Using Brentuximab vedotin Consolidation early after Auto-SCT in Hodgkin Lymphoma? - Yes - 100004

Spotlight
Video

Debate: Value to Using Brentuximab vedotin Consolidation early after Auto-SCT in Hodgkin Lymphoma? - Yes

imedex has 1238 videos Subscribe Here

Loading........
Description: In this presentation from "Lymphoma and Myeloma 2015: An International Congress on Hematologic Malignancies" Dr. Robert W. Chen argues that there is value to using brentuximab vedotin as consolidation therapy shorlty following auto-SCT in Hodgkin Lymphoma.

A continuing education program is offered as a supplement to this webcast at the following location:
http://elc.imedex.com/ELC/A...

© 2015 Imedex, LLC.
Shared By : imedex
Posted on : 05/21/16
Added : 2 years ago
Category : Hodgkin Lymphoma